Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design

Vaccine. 2022 Jun 26;40(30):3987-3988. doi: 10.1016/j.vaccine.2022.04.072.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Immunophenotyping
  • SARS-CoV-2
  • Vaccines*

Substances

  • Vaccines